top of page

Search Results

Search results for "Dongbo Bu"

Results found for "Dongbo Bu"

  • This is a Title 01 | Dr. GPCR Ecosystem

    Click on the Content Manager button in the Add panel on the left.

  • Masha Niv: Bitter Taste Receptors and the Drug Discovery Blind Spot | Dr. GPCR Ecosystem

    receptors are among the most overlooked GPCRs in pharmacology - and Masha Niv has spent her career building A computational pharmacologist by training, she built BitterDB - the first dedicated database of bitter Bitter taste receptors are built to activate, not to be blocked Bitter taste GPCRs are structurally unusual The drug bitterness blind spot persisted for decades because no one built the right tool early enough

  • Dr. Michael Feigin | Dr. GPCR Ecosystem

    Director of Graduate Studies of Experimental Therapeutics at Roswell Park Comprehensive Cancer Center in Buffalo

  • Custom Molecules, Fluorescent Probes: When Chemists Think Like Biologists with Dr. Maria Majellaro from Celtarys | Dr. GPCR Ecosystem

    GPCR and Celtarys, built on a shared commitment to empowering the GPCR research community. Now, she leads a team of six scientists and continues to build momentum through collaborations like the Translating Science into Business Like many scientists-turned-entrepreneurs, Maria faced the challenge of learning the business side of biotech on the fly. Their work directly supports the tool-building mission that aligns with the Dr. GPCR ecosystem.

  • Dr. GPCR Ecosystem

    Built for founders who prefer clarity over chaos and confusion. Biotech Decision Vault by Attila Foris Strategic Business & Operating Systems Advisor Dr.

  • Lin and Ball: GPCR Antibody Characterization and the Recombinant Shift | Dr. GPCR Ecosystem

    decade - away from polyclonal and hybridoma-based production toward recombinant monoclonal antibodies built Waste Is Not Money Ball's most direct recommendation to researchers is to contact the company before buying

  • Mark Schmeizl | Dr. GPCR Ecosystem

    He has successfully built numerous global life science, leadership teams, & works closely with both clients

  • Michel Bouvier: BRET, Biased Agonism, and the Tools That Changed GPCR Pharmacology | Dr. GPCR Ecosystem

    Michel Bouvier has spent his career building the tools to show why. BRET was built in response to a rejection The technology that would become BRET emerged from a peer-review Rather than wait, Bouvier's team submitted elsewhere and started building. The origin of BRET - dimerization controversy, marine bioluminescence, and a reviewer's demand 25:51 Building "The pharmacologists were ready to burn me for heresy, the chemists were saying, what's new, Pussycat

  • Aaron Sato: Synthetic Antibody Libraries for the Hardest GPCR Targets | Dr. GPCR Ecosystem

    Aaron Sato on building the synthetic antibody library that finally makes GPCRs tractable — and the greenfield This conversation explores how synthetic antibody phage display libraries, built on silicon-based DNA For Aaron, this work is personal: he has built his career hunting greenfield targets where others had His current focus is building synthetic phage display libraries that drug targets the field has long

  • Robert J. Lefkowitz: Beta-Adrenergic Receptors, the GPCR Family, and Fifty Years of Discovery | Dr. GPCR Ecosystem

    And I remember thinking to myself as a young buck at the time: I'm going to show this guy.

  • Anita Nivedha: Computational Dynamics of Ligand Bias in GPCR Signaling | Dr. GPCR Ecosystem

    led him into GPCR research, drug discovery, and membrane protein biology—plus practical insights on building

  • Steve McCloskey | Dr. GPCR Ecosystem

    After graduating from UCSD he founded Nanome Inc to build Virtual Reality solutions for Scientists and

  • Scaling GLP 1 Receptor Tools Through Academia Industry Collaboration | Dr. GPCR Ecosystem

    academic tool development to real-world adoption Balancing innovation with validation in GPCR assay design Building

  • GPCR Assay Strategy, Bias, and Translational Drug Discovery | Dr. GPCR Ecosystem

    Pharmacology and Executive Director of the Obesity Research Group at Eli Lilly in Boston, where he is building That shift in perspective meant accepting a program built on rightward shifted potencies. Keeping GLP1 receptors at the membrane can shape the therapeutic profile Building on work from Stephen Episode Timeline Timestamps were generated using AI for readability. - 00:00 Introduction and building

  • YC-BioTech | Dr. GPCR Ecosystem

    Home About Services News Get in Touch Welcome Biotech Growth Wherever You Are in Discovery—Let’s Build that guides program momentum Focus resources where they’ll change outcomes No More Strategy Swirl I build Build experiment timelines aligned with strategy, not spreadsheets Set up clear deliverables across internal board-ready insights Craft milestone updates that tie data to strategy Present clear next steps that build

  • Dr. Lauren M. Slosky | Dr. GPCR Ecosystem

    Program in Neuroscience, and Life Sciences Summer Undergraduate Research Program and is working to build

  • GPCR University | Dr. GPCR Ecosystem

    The rooms in your professional home University isn't a bundle of features — it's a place where your GPCR

  • YC-CRO Advisory | Dr. GPCR Ecosystem

    communication between technical teams and biotech clients • Set clear expectations and deliverables to build what biotech teams actually need • Position your services to shorten sales cycles and increase repeat business

  • Content and Conduct Policy | Dr. GPCR Ecosystem

    your Ecosystem.DrGPCR.com Account (such as the entity name, location, phone number, list of interest, business For example, do not use a photo that is a close-up of a person’s buttocks or cleavage. Harassment, Bullying, and Threats Do not engage in harassing, bullying, or threatening behavior, and GPCR conducts business Affiliate Policy Content and Conduct Policy Content Guidance Privacy Policy Terms

  • YC-VC Insights | Dr. GPCR Ecosystem

    Fast Track My Discovery The wrong CRO—or wrong experiments—can burn months and millions You're not here Build plans aligned to go/no-go moments, not busywork Drive regular check-ins that produce clear, actionable

  • Celtarys Research | Dr. GPCR Ecosystem

    MBA from the University of North Carolina, and completed the General Management Program at Harvard Business

  • Beatriz Blanco-Redondo: Adhesion GPCR Discovery in Drosophila | Dr. GPCR Ecosystem

    group leader at the University of Leipzig, uses CRISPR engineering and in vivo behavioral assays to build Remulate is the receptor she secured funding to study, the one her first PhD student built an entire The approach was systematic: generate knockouts, introduce epitope tags, observe what breaks, and build There was no shortcut available because there was no prior literature to build on. 2.

  • Content Guidelines | Dr. GPCR Ecosystem

    your Ecosystem.DrGPCR.com Account (such as the entity name, location, phone number, list of interest, business For example, do not use a photo that is a close-up of a person’s buttocks or cleavage. Harassment, Bullying, and Threats Do not engage in harassing, bullying, or threatening behavior, and GPCR conducts business Affiliate Policy Content and Conduct Policy Content Guidance Privacy Policy Terms

  • Affiliate Policy | Dr. GPCR Ecosystem

    participating in the Affiliates Program: “Cash-back” or voucher sites (websites that offer rewards for buying GPCR conducts business Affiliate Policy Content and Conduct Policy Content Guidance Privacy Policy Terms

  • Terms and Conditions | Dr. GPCR Ecosystem

    If you are entering into this ATS on behalf of a company, business, or other legal entity, you represent SERVICES: Ecosystem.DrGPCR.com is an online platform that provides to (i) individuals and businesses and market their services and products related to the biotech industry; and to (ii) individuals and businesses who are seeking to buy, to sell, to invest, to rent, or those who wish to find services to assist or Individuals and businesses under this section are defined as “Customer” or “Customers”.

  • Media Partner Packages | Dr. GPCR Ecosystem

    long-term ecosystem initiatives Be consistently visible across trusted educational and content platforms Build Build Trust Develop content that speaks their language and establishes your credibility in the GPCR research

  • Dr GPCR Ecosystem Feedback | Dr. GPCR Ecosystem

    GPCR Community Survey Help us build the next evolution of the GPCR Ecosystem — together. Build stronger connections between academia and industry. Expand our shared knowledge base Support students and researchers entering the field Together, we’re building

  • University Pricing | Dr. GPCR Ecosystem

    learn, connect, and advance together — with expert-led courses, live masterclasses, and career tools built Built for teams aligning pharmacology across programs — so everyone works from the same expert-led foundation monthly AMA's — the complete GPCR learning experience in one membership. $2999/year Per person Get the Bundle

  • Trademark Policy | Dr. GPCR Ecosystem

    GPCR buttons. GPCR button. GPCR Buttons. By using a Dr. GPCR button, Publishers give Dr. GPCR button. GPCR buttons.

  • Timeline Strategy | Scaling Biotech Operations with Dr. GPCR

    Cross-functional Team Alignment Scaling Protocols & Decision Architecture From Chaos to Scale Timeline Strategy built Build clarity → align people, process, priorities. 3. Scale with confidence → expand without burnout. Building the Strategic Backbone of GPCR Innovation In the rapidly evolving GPCR field, scientific progress organizations: ✅ Clarify vision and direction ✅ Translate research milestones into measurable objectives ✅ Build

bottom of page